Citation: M. Rosenfeld et al., AEROSOLIZED ANTIBIOTICS FOR BACTERIAL LOWER AIRWAY INFECTIONS - PRINCIPLES, EFFICACY, AND PITFALLS, Infectious diseases in clinical practice, 7(2), 1998, pp. 66-79
Authors:
PIEDRA PA
POVEDA GA
RAMSEY B
MCCOY K
HIATT PW
Citation: Pa. Piedra et al., INCIDENCE AND PREVALENCE OF NEUTRALIZING ANTIBODIES TO THE COMMON ADENOVIRUSES IN CHILDREN WITH CYSTIC-FIBROSIS - IMPLICATION FOR GENE-THERAPY WITH ADENOVIRUS VECTORS, Pediatrics, 101(6), 1998, pp. 1013-1019
Authors:
WEBER A
MORLIN G
COHEN M
WILLIAMSWARREN J
RAMSEY B
SMITH A
Citation: A. Weber et al., EFFECT OF NEBULIZER TYPE AND ANTIBIOTIC CONCENTRATION ON DEVICE PERFORMANCE, Pediatric pulmonology, 23(4), 1997, pp. 249-260
Authors:
SMITH A
WEBER A
PANDHER R
WILLIAMSWARREN J
COHEN ML
RAMSEY B
Citation: A. Smith et al., UTILIZATION OF SALIVARY CONCENTRATIONS OF CIPROFLOXACIN IN SUBJECTS WITH CYSTIC-FIBROSIS, Infection, 25(2), 1997, pp. 106-108
Citation: A. Bolotnikov et B. Ramsey, THE SPECTROSCOPIC PROPERTIES OF HIGH-PRESSURE XENON, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 396(3), 1997, pp. 360-370
Citation: A. Bolotnikov et B. Ramsey, IMPROVING THE ENERGY RESOLUTION OF HIGH-PRESSURE XE CYLINDRICAL IONIZATION CHAMBERS, IEEE transactions on nuclear science, 44(3), 1997, pp. 1006-1010
Citation: A. Bolotnikov et B. Ramsey, PURIFICATION TECHNIQUES AND PURITY AND DENSITY-MEASUREMENTS OF HIGH-PRESSURE XE, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 383(2-3), 1996, pp. 619-623
Citation: B. Ramsey, GOD, COSMOS, AND HUMANKIND - THE WORLD OF EARLY-CHRISTIAN SYMBOLISM -LADNER,GB, DUNLAP,T, Theological studies, 57(4), 1996, pp. 775-776
Authors:
STARKEBAUM G
MANNIK M
SHASTEEN NM
FLEMINGJONES R
MILLER R
RAMSEY B
Citation: G. Starkebaum et al., ANTIBODIES TO RECOMBINANT HTLV-I ENVELOPE GP21 IN RHEUMATOID-ARTHRITIS (RA), Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 114-114
Authors:
MORRIS NH
SOORANNA SR
LEARMONT JG
POSTON L
RAMSEY B
PEARSON JD
STEER PJ
Citation: Nh. Morris et al., NITRIC-OXIDE SYNTHASE ACTIVITIES IN PLACENTAL TISSUE FROM NORMOTENSIVE, PREECLAMPTIC AND GROWTH-RETARDED PREGNANCIES, British journal of obstetrics and gynaecology, 102(9), 1995, pp. 711-714
Authors:
HUNT BE
WEBER A
BERGER A
RAMSEY B
SMITH AL
Citation: Be. Hunt et al., MACROMOLECULAR MECHANISMS OF SPUTUM INHIBITION OF TOBRAMYCIN ACTIVITY, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 34-39
Authors:
FIEL SB
FUCHS HJ
JOHNSON C
GONDA I
CLARK AR
CIPOLLA CC
COLIN A
COLOMBO J
DENNING C
DOZOR A
EIGEN H
EISENBERG J
FINK R
GELLER D
GERSTLE R
GLASSER L
GREEN C
HERNRIED L
JOHNSON G
JONE K
KASLOVSKY R
KIRCHNER K
LIGHT M
LLOYDSTILL JD
MAJURE M
MARSHALL B
MCCOY K
MCKEAN LP
MOSS R
NASR S
NICKERSON B
RAMSEY B
REGELMANN W
ROCK MJ
ROSENSTEIN BJ
SCHIDLOW D
SCHNAPF B
SHAY G
SINDEL L
SPIRITUS E
STOKES DC
STONE R
SWARTZ DR
Citation: Sb. Fiel et al., COMPARISON OF 3 JET NEBULIZER AEROSOL DELIVERY SYSTEMS USED TO ADMINISTER RECOMBINANT HUMAN DNASE-I TO PATIENTS WITH CYSTIC-FIBROSIS, Chest, 108(1), 1995, pp. 153-156
Authors:
WANG JP
UNADKAT JD
MCNAMARA S
OSULLIVAN TA
SMITH AL
TRAGER WF
RAMSEY B
Citation: Jp. Wang et al., DISPOSITION OF DRUGS IN CYSTIC-FIBROSIS .11. IN-VIVO ACTIVITY OF CYTOCHROME-P450 ISOFORMS INVOLVED IN THE METABOLISM OF (R)-WARFARIN (INCLUDING P450 3A4) IS NOT ENHANCED IN CYSTIC-FIBROSIS, Clinical pharmacology and therapeutics, 55(5), 1994, pp. 528-534